Jake_young2016-07-22 11:10
$ZS Pharm(ZSPH)$ 和$Relypsa(RLYP)$ 都被收了,时间长波动大没把握住。下一个会是$Depomed(DEPO)$ 吗?查看全文
二遍水2016-05-10 21:15
这是之前写的一篇文章,已经发表在生物谷。
Relypsa, 会是下一个并购对象吗?
Relypsa创立于2007年,位于加州RedWood(大名鼎鼎的Oracle的总部就位于此)。公司主要从事非吸收聚合类药物的开发和商业化,专注于肾脏和代谢性疾病领域,其核心技术为高分子聚合物的开发技术平台。
2013年9月...查看全文
ddzan2016-04-08 00:55
$RELYPSA(RLYP)$ 买到了~虽然不多——Relypsa working with Centerview Partners to review offers from potential buyers -- Reuters, citing sources查看全文
淡投2016-02-23 06:59
M: $爱力根医疗(AGN)$
T: $Intercept Pharmaceuticals(ICPT)$
W: $RELYPSA(RLYP)$ $Sage Therapeutics(SAGE)$
T: $阿尔凯默斯(ALKS)$ $塞德斯医疗(CLDX)$ $Clovis Oncology(CLVS)$
F: $爱美医疗(FOLD)$查看全文
美股实战学院2016-01-08 14:20
个股关注:做空股逢高:$史密斯威森(SWHC)$ (看情况)$SunEdison(SUNE)$ KMI $RELYPSA(RLYP)$ $阿卡迪亚(ACAD)$ $晶科能源(JKS)$ 动能股逢低买:$德纳维制药(DVAX)$ $花旗(C)$ $500彩票网(WBAI)$ $uniQure(QURE)$ BIOC HTBX Netflix(NFLX) 反弹股:LL LEI $苹果(AAPL)$ SWHC RGG(看情况)
具...查看全文
$RELYPSA(RLYP)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2016-01-05 AccNo: 0001193125-16-421403 Size: 307 KB 网页链接
$RELYPSA(RLYP)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2015-12-24 AccNo: 0000947871-15-000887 Size: 170 KB 网页链接
$RELYPSA(RLYP)$ 8-K - Current report Filed: 2015-12-22 AccNo: 0001193125-15-410738 Size: 36 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$RELYPSA(RLYP)$ 8-K - Current report Filed: 2015-12-21 AccNo: 0001193125-15-408456 Size: 18 KBItem 8.01: Other Events 网页链接
$RELYPSA(RLYP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-12-14 AccNo: 0001172661-15-002117 Size: 139 KB 网页链接
$RELYPSA(RLYP)$ 内部交易: 2015-12-07,Chief Medical Officer and SVP,Berman Lance ,卖出,30000普通股, $29.78
$RELYPSA(RLYP)$ 内部交易: 2015-12-09,Chief Medical Officer and SVP,Berman Lance ,卖出,750普通股, $29.50
$RELYPSA(RLYP)$ 内部交易: 2015-12-09,Chief Medical Officer and SVP,Berman Lance ,期权,750普通股, $7.40
$RELYPSA(RLYP)$ 内部交易: 2015-12-07,Chief Medical Officer and SVP,Berman Lance ,期权,30000普通股, $4.51
$RELYPSA(RLYP)$ 内部交易: 2015-12-07,总裁 & CEO,Orwin John A ,卖出,15000普通股, $28.28